Medicine
Rifampin 150 mg capsule
Rifampin 150 mg capsule is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25º C (68º to 77º F) Dispense contents in a tight…
Key facts
- Active ingredient (INN)
- Rifampin
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 30 capsules, 100 capsules, 30 blister pack and 6 more
- Manufacturers
- LupinIndiaANI PharmaceuticalsEpic PharmaAmerican Health PackagingBlu PharmaceuticalsChartwell RXCoupler
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25º C (68º to 77º F) Dispense contents in a tight light-resistant container as defined in the USP with a child resistant closure, as required. Store in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J04AB02 Rifampin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 April 2008
- Identifiers
- RxCUI 198201, 198202DailyMed set ID 0391f1e1-70d4-4b15-8b58-055bb6a385b8, b56004f0-f23d-47f6-80c7-39884fccbccc, b389b1a3-672f-47e3-916c-4a9c044b211b +4NDC 42806-801, 68180-658, 70954-892 +4Application ANDA064150, ANDA090034, ANDA219918 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 capsule in 1 bottle | 68180-658-06 | LupinIndia | 8 January 2014 |
| 30 capsule in 1 bottle | 70954-892-10 | ANI Pharmaceuticals | 20 July 2026 |
| 100 capsule in 1 bottle | 70954-892-20 | ANI Pharmaceuticals | 20 July 2026 |
| 30 capsule in 1 bottle | 24658-801-30 | Blu Pharmaceuticals | 14 March 2023 |
| 30 capsule in 1 bottle | 62135-315-30 | Chartwell RX | 5 April 2023 |
| 100 capsule in 1 bottle | 42806-801-01 | Epic Pharma | 15 December 2021 |
| 30 capsule in 1 bottle | 42806-801-30 | Epic Pharma | 15 December 2021 |
| 30 blister pack in 1 box, unit-dose / 1 capsule in 1 blister pack | 60687-575-21 | American Health Packaging | 5 March 2021 |
| 30 capsule in 1 blister pack | 67046-1605-3 | Coupler | 13 October 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 May 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Rifampin
Clinical summary
Rifampin is a rifamycin antibacterial indicated in the treatment of all forms of tuberculosis, among other approved uses. It is available as capsules and powder for injection for oral and intravenous use. MedsAcross supplies Rifampin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RifampinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Rifampin prescribing information (Mylan Institutional) · U.S. National Library of Medicine, DailyMed
Need Rifampin 150 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.